CP-366660

N/A

Report date: 2023/05/22 10:18:10

Base Information

Drug NameCP-366660
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionT cell activation inhibitorsVoltage-gated potassium channel subunit Kv1.3 blockers
TargetsPotassium channelVoltage-gated potassium channel subunit Kv1.3
Therapy Area/Indications +[1]  N/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive Indications +[1]  N/A

Other Information

ATC CodeN/A
Related LinksN/A